Sleep Disorders & Neurology
Narcolepsy Clinical Research
Narcolepsy is a chronic neurological disorder that affects the brain’s ability to regulate sleep-wake cycles. CenExel partners with sponsors to advance innovative narcolepsy treatments through specialized clinical research, experienced investigators, and diverse patient populations.
Studies Conducted
0
+
Trial Participants
0
+
Active Centers
0
Overview
Advancing Narcolepsy Research & Treatment
CenExel supports clinical trials focused on narcolepsy and excessive daytime sleepiness with scientific precision and patient-centered care. Our experienced research teams help sponsors evaluate new therapies designed to improve sleep quality, wakefulness, and overall quality of life for patients living with narcolepsy.
Conditions Covered
Narcolepsy & Sleep Disorders We Research
Our research sites support a broad range of sleep disorder and neurological studies, helping sponsors evaluate innovative therapies across different patient populations.
- Narcolepsy Type 1
- Narcolepsy Type 2
- Excessive Daytime Sleepiness (EDS)
- Cataplexy
- Sleep Paralysis
- Hypersomnia
- Obstructive Sleep Apnea
- Shift Work Sleep Disorder
Our Approach
Why Sponsors Choose CenExel for Narcolepsy Research
CenExel provides scientific expertise, strong patient recruitment, and operational excellence to help sponsors accelerate narcolepsy clinical trials from startup through closeout.
01
Specialized Sleep Research Expertise
Our investigators have experience conducting neurological and sleep disorder studies with high-quality data collection and patient engagement.
02
Advanced Recruitment Strategies
We use targeted outreach and patient databases to support rapid enrollment for narcolepsy and sleep disorder trials.
03
Diverse Patient Populations
Our nationwide site network provides access to broad and diverse patient populations across multiple demographics.
04
Reliable Trial Execution
CenExel sites consistently deliver efficient study startup, retention, and data quality throughout the clinical trial lifecycle.
Phase Coverage
Supported Narcolepsy Trial Phases
CenExel supports early and late-phase narcolepsy and sleep disorder clinical research, from first-in-human studies through Phase IV post-market trials.
Active across all phases
- Phase I
- Phase II
- Phase III
- Phase IV
Our research teams support biomarker strategies, patient monitoring, and endpoint analysis for sleep disorder and neurological clinical trials.
Let’s Advance Your Next Study
Looking for an experienced clinical research partner with the expertise, capabilities, and reach to move your study forward? Connect with CenExel to discuss your needs and explore how our network can support your clinical development goals.
Explore Our Network
Discover CenExel’s Centers of Excellence and find the locations, therapeutic expertise, and capabilities that align with your clinical development needs.
